These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2405585)

  • 1. Oral fluoroquinolone versus mono- or combination parenteral therapy in the management of bacterial infections: a critical appraisal.
    Guay DR
    DICP; 1990 Jan; 24(1):11-8. PubMed ID: 2405585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of oral fluoroquinolones as an alternative to traditional parenteral therapy for patients with serious infections.
    Ball P
    Clin Invest Med; 1989 Feb; 12(1):69-70. PubMed ID: 2920483
    [No Abstract]   [Full Text] [Related]  

  • 3. Imipenem monotherapy versus combination therapy in the management of mixed bacterial infection: a critical appraisal.
    Jaresko GS; Barriere SL
    Pharmacotherapy; 1988; 8(6):324-33. PubMed ID: 3222165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing considerations in fluoroquinolone therapy.
    Gentry LO
    Pharmacotherapy; 1993; 13(2 Pt 2):39S-44S. PubMed ID: 8474937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New oral and parenteral quinolones. A summary.
    Neu HC
    Am J Med; 1989 Nov; 87(5A):283S-287S. PubMed ID: 2589378
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of quinolones in the treatment of infections of the skin and skin structure.
    Gentry LO
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():97-110. PubMed ID: 1787128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of bacterial isolates from AIDS patients to six fluoroquinolones.
    Lewin CS; Naden M; Watt B; Amyes SG
    J Pharm Pharmacol; 1990 Nov; 42(11):808-9. PubMed ID: 1982310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolones in the aged.
    Nicolle LE
    Drugs; 1999; 58 Suppl 2():49-51. PubMed ID: 10553705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.
    Janknegt R
    Pharmacoeconomics; 1994 Jul; 6(1):15-33. PubMed ID: 10147351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrofloxacin in salmonids.
    Bowser PR; Babish JG
    Vet Hum Toxicol; 1991; 33 Suppl 1():46-8. PubMed ID: 1926748
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of fluoroquinolones in respiratory tract infections.
    Grossman RF
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():59-62. PubMed ID: 9484874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group.
    Mattina R; Cocuzza CE; Cesana M
    Infection; 1993; 21(2):106-11. PubMed ID: 8387963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
    Rizk E
    Am J Med; 1992 Apr; 92(4A):130S-135S. PubMed ID: 1316063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gatifloxacin: a review of its use in the management of bacterial infections.
    Perry CM; Ormrod D; Hurst M; Onrust SV
    Drugs; 2002; 62(1):169-207. PubMed ID: 11790160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C
    Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolones for short-term treatment of uncomplicated urinary tract infection.
    Kadiri S; Ajayi SO; Toki RA
    East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.
    Maschmeyer G
    Drugs; 1993; 45 Suppl 3():73-80. PubMed ID: 7689455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolone generations: natural history or natural selection?
    Ball P
    J Antimicrob Chemother; 2000 Jul; 46 Suppl T1():17-24. PubMed ID: 10997595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug positioning of parenteral fluoroquinolones in management of infectious diseases. Discussion].
    Kobayashi H; Aikawa N; Saito A; Shuden S; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):345-60. PubMed ID: 12378867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.